Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

None of the other small cap pharmas have been successful running a full Phase 2 trial. I agree, we have a possible Winner here Smoki.
Ifenprodil has proven effective with helping patients with low O'2 levels and IL-6 issues. These results may have benefits for other patients besides for COVID and long-haulers. Acknowledgement of these results by the FDA will certainly make future plans of financing for Ifenprodil and/or other paths AGN might follow easier. Success will build confidence, IMO.
The obvious Dec Interim data presentation failure and inept evaluation of that data has been hard to overcome. We can hope that the presentations to the FDA will be complete and competent...GLTA...